Who invested in Dewpoint Therapeutics

3 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 3 months ago

Funding summaryUpdated 26 Oct 2026

$196Mraised across 3 rounds since 2019, from 3 sources

$60MSeries A$59MSeries D$77MRound

Latest round: Round, $77MJul 2026
Step-upi: 1.3×
Investors: 11

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023202420252026

$60MSeries A$59MSeries D$77MRound

First round: Series A, $60M
Biggest round: $77M
Usual gap between rounds: 6.6 years

The rounds

Jul 2026
Round$77M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $77M sold, first sale Jul 2026
Sept 2025
Series D$59M6 new
Source recordedSEC filing: $59M sold, first sale Sept 2025
Jan 2019
Series A$60M5 new
- Alexandria Real Estate Equities
- EcoR1 Capital
- 6 Dimensions Capital
- Leaps by Bayer
- Polaris Partners/ Samsara BioCapital
Reported by FinSMEs

Founders and team

From Dewpoint Therapeutics's own website: 14 on the team.

Ameet NathwaniChief Executive Officer
Ann BoijaChief Scientific Officer
Isaac KleinChief Development and Operating Officer
Avinash PatelHead of Early Discovery
Dean MulaHead of Finance & Accounting
Francis CarpenterSVP, Head of Technology and Corporate Strategy
Nino JeenaHead of Financial Planning & Analysis
Amir NashatChair of the Board of Directors
Giuseppe CiaramellaBoard Member
Mark MurckoBoard Member
Olivier BrandicourtBoard Member
Regina BarzilayBoard Member
Srinivas AkkarajuBoard Member
Steven NeierBoard Member

AdvisersPhillip Sharp

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2019Series D2025Round2026

General Catalyst

ARCH Venture Partners

SoftBankSoftBank Vision Fund

Alexandria Real Estate Equities

Samsara BioCapitalMaverick Ventures

EcoR1 Capital

6 Dimensions Capital

Leaps by Bayer

Everyone who backed them

General CatalystVC firm1round

ARCH Venture PartnersVC firm1round

SoftBankInvestment firm1round

SoftBank Vision FundVC firm1round

Alexandria Real Estate EquitiesVC firm1round

Samsara BioCapitalVC firm1round

Maverick VenturesVC firm1round

EcoR1 CapitalPrivate equity1round

6 Dimensions CapitalVC firm1round

Leaps by BayerCorporate VC1round

Polaris Partners/ Samsara BioCapitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Dewpoint Therapeutics

Who invested in Dewpoint Therapeutics?

Dewpoint Therapeutics's investors include General Catalyst, ARCH Venture Partners, SoftBank, SoftBank Vision Fund and Alexandria Real Estate Equities, and 6 more on record.

How much has Dewpoint Therapeutics raised?

Dewpoint Therapeutics has raised $196M across 3 rounds since 2019.

When did Dewpoint Therapeutics last raise?

Dewpoint Therapeutics's most recent round, $77M, was in Jul 2026.

What was Dewpoint Therapeutics's biggest round?

Its most recent round, $77M in Jul 2026, is also its largest on record.

Who backed Dewpoint Therapeutics first?

Dewpoint Therapeutics's first round on record, in Jan 2019, was backed by Alexandria Real Estate Equities, EcoR1 Capital and 6 Dimensions Capital and 2 others.